| Department: |
Condition
(as stated in title): |
PI Name: |
IRB #: |
| Bone Marrow Transplant |
Hematologic Malignancies |
Emmons, Robert |
12201 |
| IRB Approval Valid Through: December 2010 |
| Status of Trial: Open but closed to enrollment |
|
| Bone Marrow Transplant |
Hematologic Malignancies |
Emmons, Robert |
4471 |
| IRB Approval Valid Through: September 2010 |
| Status of Trial: Open but closed to enrollment |
|
| Bone Marrow Transplant |
Chronic Myeloid Leukemia (CML) |
Emmons, Robert |
11337 |
| A phase II open-label study of the subcutaneous administration of Homoharringtonine (CGX-635) in the treatment of patients with chronic myeloid leukemia (CML) with T3151 BCR-ABL gene mutation (CGX 635-CML-202) |
| IRB Approval Valid Through: September 2010 |
| Status of Trial: Open but closed to enrollment |
|
| Bone Marrow Transplant |
Chronic Myeloid Leukemia (CML) |
Emmons, Robert |
11338 |
| A phase II open-label study of the subcutaneous administration of Homoharringtonine (CGX-635) in the treatment of patients with chronic myeloid leukemia (CML) who have failed or are intolerant to Tyrosine Kinase Inhibitor Therapy (CGX-6350CML-203) |
| IRB Approval Valid Through: December 2010 |
| Status of Trial: Open but closed to enrollment |
|
| Bone Marrow Transplant |
AML |
Emmons, Robert |
11426 |
| IRB Approval Valid Through: January 2011 |
| Status of Trial: Open to recruitment |
|
| Bone Marrow Transplant |
Large B-Cell Lymphoma |
|
11664 |
| A phase I study of the monoclonal antibody CT-011 in patients with diffuse Large B-Cell Lymphoma following autologous peripheral blood stem cell transplantation |
| IRB Approval Valid Through: May 2011 |
| Status of Trial: Open but closed to enrollment |
|
| Bone Marrow Transplant |
Gastrointestinal Graft Disease |
Martin, Maryellen |
12469 |
| A phase I randomized, double-blind, placebo-controlled, multi-center study of the safety and efficacy of ORBEC (Oral Beciomethasone 17,21-Dippropionate) in conjunction with ten days of high-dose prednisone therapy in the treatment of patients with gastrointestinal graft vs. host disease |
| IRB Approval Valid Through: August 2010 |
| Status of Trial: Open to recruitment |
| |